51
Growth Score in past quarter
pts
Heat Score 51 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
439691
Link Immunotherapeutics develops therapies with a focus on known cancer targets and bispecific architectures.
- Eric Gruff: Chief Development Officer (CDO)Past Role: Lengo Therapeutics, Senior Vice President, Chemistry, Manufacturing & Controls (CMC)
About the Company
Link Immunotherapeutics specializes in creating therapies through rigorous science and high-throughput observation. It focuses on known cancer targets and bispecific architectures, building on existing understanding in the pursuit of better molecules with greater patient benefit.